Two Foundations Unite Behind $5 Million Push to Crack an Elusive Blood Cancer
Blood Cancer United and the Edward P. Evans Foundation are jointly funding a five-year, $5 million Specialized Center of Research ...
Blood Cancer United and the Edward P. Evans Foundation are jointly funding a five-year, $5 million Specialized Center of Research ...
A survey of 56 hematologists reveals how specialists manage extreme thrombocytosis in essential thrombocythemia and how closely their decisions align ...
A retrospective study of 354 patients found clonal T-large granular lymphocyte expansions in 17.2 percent of JAK2-mutated myeloproliferative neoplasm cases, ...
A new systematic review finds that mutations, methylation, and expression loss of the ATM DNA repair gene are recurrent and ...
A large propensity score-matched database analysis finds that pregnancies complicated by myeloproliferative neoplasms carry significantly higher risks of death, hypertensive ...
The Danish DALIAH phase 3 trial found that low-dose pegylated interferon achieved superior long-term molecular responses to hydroxyurea in myeloproliferative ...
Single-cell multiomics of blood stem cells from myeloproliferative neoplasm patients shows that interferon-α normalizes blood counts by boosting lymphoid differentiation ...
In a remarkable advancement in the field of hematology and cancer biology, researchers have uncovered a critical role played by ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine